Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

Phase I trials begin for Fabry's disease

Jan. 24, 1997

Muse licensed to Janssen for certain markets

Jan. 24, 1997

GelTex reports CholestaGel phase II data

Jan. 24, 1997

Positive phase II results reported for platelet substitute

Jan. 24, 1997

Additional beneficial lipid-modifying effects of FCP-3P1 reported

Jan. 24, 1997

Cerebrus discovers role of gene in obesity

Jan. 24, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

NESP enters clinical trials

Jan. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...